Roflumilast cream, a once-daily, potent phosphodiesterase-4 inhibitor, in chronic plaque psoriasis patients: Efficacy and safety from DERMIS-1 and DERMIS-2 Phase 3 trials
Authors: Mark Lebwohl, Leon H Kircik, Angela Moore, Linda Stein Gold, Zoe D. Draelos, Melinda J Gooderham, Kim A Papp, Jerry Bagel, Neal Bhatia, James Del Rosso, Laura K Ferris, Lawrence J Green, Adelaide A Hebert, Terry Jones, Steven E Kempers, David M Pariser, Paul S Yamauchi, Matthew Zirwas, Patrick Burnett, Robert C Higham, Lynn Navale, David R Berk